Exclusive from Jason Mast and Brian Yang at @statnews.com who write "the disclosure raises concerns about the quality and transparency of China’s more lightly regulated pathway for drug trials." www.statnews.com/2026/08/05/c...
Once again, child dies in gene editing trial in China, rekindling debate on transparency and safety
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: what "bothers me is the lack of transparency.'
statnews.com